EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pregnancy in Lysinuric Protein Intolerance Complicated by Immune Dysregulation and Severe Thrombocytopenia

Eamon P McCarron iD, Melanie Hill, Adam Lomas, Victoria Elliott, Emma Walkinshaw, Tessa Bonnett, Kar-Ping Kuet, Rachel Tattersall, Claire Mapplebeck

JIMD Reports · 2026-07 · 67 (4)

DOI: 10.1002/jmd2.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JIMD Reports, online erschienen am 03.07.2026. Verfasst von Eamon P McCarron und 8 weiteren Autor:innen. Beteiligte Einrichtung: Adult Inherited Metabolic Disorders, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysinuric protein intolerance (LPI) is a rare disorder of dibasic amino acid transport associated with secondary urea cycle defects and immune dysregulation. Pregnancy in LPI is seldom reported and presents significant management challenges. We report a 25‐year‐old woman with genetically confirmed LPI complicated by prior hemophagocytic lymphohistiocytosis (HLH) and systemic lupus erythematosus (SLE) who presented with an unplanned pregnancy. Early gestation was characterised by metabolic instability, including transient hyperammonaemia and elevated orotic acid, which improved with optimisation of nitrogen scavenger therapy and nutritional support. Progressive severe thrombocytopenia and anaemia developed during the second trimester and were managed as presumed immune thrombocytopenia with corticosteroids and intravenous immunoglobulin. Delivery by caesarean section at 35 weeks resulted in favourable maternal and neonatal outcomes. To our knowledge, this represents the first reported case of pregnancy in LPI complicated by established immune dysregulation (HLH and SLE) and severe thrombocytopenia, defining a previously uncharacterised high‐risk phenotype with a favourable outcome.

Schlagwörter

Stichwörter der Autor:innen

hyperammonaemiaimmune dysregulationlysinuric protein intolerancepregnancythrombocytopenia

Autor:innen und Institutionen

  • Adult Inherited Metabolic Disorders, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
  • Faculty of Health, University of Sheffield Sheffield UK.
  • The Yorkshire & Humber Maternal Medicine Network Sheffield UK.
  • Endocrinology Department Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
  • Obstetrics and Maternal Medicine, Jessop Wing, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.
  • Rheumatology Department Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.

ORCID-Profile: Eamon P McCarron

Zitieren

APA

McCarron, E. P., Hill, M., Lomas, A., Elliott, V., Walkinshaw, E., Bonnett, T., Kuet, K. P., Tattersall, R., & Mapplebeck, C. (2026). Pregnancy in Lysinuric Protein Intolerance Complicated by Immune Dysregulation and Severe Thrombocytopenia. JIMD Reports, 67(4). https://doi.org/10.1002/jmd2.70109

Vancouver

McCarron EP, Hill M, Lomas A, Elliott V, Walkinshaw E, Bonnett T, et al. Pregnancy in Lysinuric Protein Intolerance Complicated by Immune Dysregulation and Severe Thrombocytopenia. JIMD Reports. 2026;67(4). doi:10.1002/jmd2.70109

BibTeX
@article{McCarron2026,
  author = {McCarron, Eamon P and Hill, Melanie and Lomas, Adam and Elliott, Victoria and Walkinshaw, Emma and Bonnett, Tessa and Kuet, Kar-Ping and Tattersall, Rachel and Mapplebeck, Claire},
  title = {Pregnancy in Lysinuric Protein Intolerance Complicated by Immune Dysregulation and Severe Thrombocytopenia},
  journal = {JIMD Reports},
  year = {2026},
  volume = {67},
  number = {4},
  doi = {10.1002/jmd2.70109}
}
Kostenlos starten →